Angiopoietin-like proteins, including ANGPTL2, have also been analyzed as oncological biomarkers and therapeutic targets in tumor angiogenesis, and they are implicated in cardiovascular diseases, such as heart failure and atherosclerosis [150,151]. This evidence concerns the gene ANGPTL2 and cardiovascular disorder.